Access the full text.
Sign up today, get DeepDyve free for 14 days.
H. Hemmati, I. Nakano, J. Lazareff, M. Masterman‐Smith, D. Geschwind, M. Bronner‐Fraser, H. Kornblum (2003)
Cancerous stem cells can arise from pediatric brain tumorsProceedings of the National Academy of Sciences of the United States of America, 100
P. Rosée, Lei Shen, E. Stoffregen, M. Deininger, B. Druker (2003)
No correlation between the proliferative status of Bcr-Abl positive cell lines and the proapoptotic activity of imatinib mesylate (Gleevec/Glivec).The hematology journal : the official journal of the European Haematology Association, 4 6
L. Weisenthal, M. Lippman (1985)
Clonogenic and nonclonogenic in vitro chemosensitivity assays.Cancer treatment reports, 69 6
Lyn MickleyS, S. Bates, Nancy RichertS, S. Currier, Shigen Tanakas, Francine Fossi, Neal Rosenll, A. Fojo (1989)
Modulation of the expression of a multidrug resistance gene (mdr-1/P-glycoprotein) by differentiating agents.The Journal of biological chemistry, 264 30
H. Hahn, C. Wicking, P. Zaphiropoulos, M. Gailani, S. Shanley, A. Chidambaram, I. Vořechovský, E. Holmberg, A. Undén, Susan Gillies, K. Negus, I. Smyth, C. Pressman, D. Leffell, B. Gerrard, A. Goldstein, M. Dean, R. Toftgård, G. Chenevix-Trench, B. Wainwright, A. Bale (1996)
Mutations of the Human Homolog of Drosophila patched in the Nevoid Basal Cell Carcinoma SyndromeCell, 85
C. Jamieson, L. Ailles, S. Dylla, M. Muijtjens, Carol Jones, J. Zehnder, J. Gotlib, Kevin Li, M. Manz, A. Keating, C. Sawyers, I. Weissman (2004)
Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML.The New England journal of medicine, 351 7
J. Gioanni, M. Farges, H. Duplay, M. Héry, E. Zanghellini, M. Schneider, C. Mazeau, M. Namer, A. Courdi (1988)
In vitro clonogenicity in relation to kinetic and clinicopathological features of breast cancer.Bulletin du cancer, 75 3
K. Nishiyama, T. Shirahama, A. Yoshimura, T. Sumizawa, T. Furukawa, Misako Ichikawa‐Haraguchi, S. Akiyama, Y. Ohi (1993)
Expression of the multidrug transporter, P‐glycoprotein, in renal and transitional cell carcinomasCancer, 71
Kristin Hope, Liqing Jin, J. Dick (2004)
Acute myeloid leukemia originates from a hierarchy of leukemic stem cell classes that differ in self-renewal capacityNature Immunology, 5
R. Summer, D. Kotton, Xi Sun, B. Ma, K. Fitzsimmons, A. Fine (2003)
Side population cells and Bcrp1 expression in lung.American journal of physiology. Lung cellular and molecular physiology, 285 1
G. Cotsarelis, S. Millar (2001)
Towards a molecular understanding of hair loss and its treatment.Trends in molecular medicine, 7 7
(2003)
A phase II study of paclitaxel/CBT–1, an MDR modulator
Ronald Johnson, Alana Rothman, Jingwu Xie, L. Goodrich, J. Bare, J. Bonifas, A. Quinn, R. Myers, David Cox, E. Epstein, M. Scott (1996)
Human Homolog of patched, a Candidate Gene for the Basal Cell Nevus SyndromeScience, 272
S. Yu, J. Zhang, C. Zhao, H. Zhang, Q. Xu (2004)
Isolation and characterization of the CD133+ precursors from the ventricular zone of human fetal brain by magnetic affinity cell sortingBiotechnology Letters, 26
(2003)
Stem cells in normal breast development and breast cancer
Bob Liu, S. McDermott, S. Khwaja, C. Alexander (2004)
The transforming activity of Wnt effectors correlates with their ability to induce the accumulation of mammary progenitor cellsProceedings of the National Academy of Sciences of the United States of America, 101
Cindy Martin, A. Meeson, S. Robertson, T. Hawke, J. Richardson, S. Bates, S. Goetsch, T. Gallardo, D. Garry (2004)
Persistent expression of the ATP-binding cassette transporter, Abcg2, identifies cardiac SP cells in the developing and adult heart.Developmental biology, 265 1
C. Hirschmann-Jax, A. Foster, Gerald Wulf, G. Wulf, J. Nuchtern, T. Jax, U. Gobel, M. Goodell, M. Brenner (2004)
A distinct "side population" of cells with high drug efflux capacity in human tumor cells.Proceedings of the National Academy of Sciences of the United States of America, 101 39
A. Schinkel, J. Smit, O. Tellingen, J. Beijnen, E. Wagenaar, L. Deemter, C. Mol, M. Valk, E. Robanus-Maandag, H. Riele, A. Berns, P. Borst (1994)
Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugsCell, 77
CM Southam, A Brunschwig (1960)
Quantitative studies of autotransplantation of human cancerCancer, 14
S. Morrison, Antoni Wandycz, H. Hemmati, Douglas Wright, I. Weissman (1997)
Identification of a lineage of multipotent hematopoietic progenitors.Development, 124 10
W. Hofmann, M. Komor, B. Wassmann, L. Jones, H. Gschaidmeier, D. Hoelzer, H. Koeffler, O. Ottmann (2003)
Presence of the BCR-ABL mutation Glu255Lys prior to STI571 (imatinib) treatment in patients with Ph+ acute lymphoblastic leukemia.Blood, 102 2
Sheila Singh, C. Hawkins, I. Clarke, J. Squire, J. Bayani, T. Hide, R. Henkelman, M. Cusimano, M. Cusimano, P. Dirks (2004)
Identification of human brain tumour initiating cellsNature, 432
P. Andrews (2002)
From teratocarcinomas to embryonic stem cells.Philosophical transactions of the Royal Society of London. Series B, Biological sciences, 357 1420
C. Blanpain, W. Lowry, A. Geoghegan, Lisa Polak, E. Fuchs (2004)
Self-Renewal, Multipotency, and the Existence of Two Cell Populations within an Epithelial Stem Cell NicheCell, 118
L. Mickley, B. Spengler, Turid Knutsen, J. Biedler, Tito Fojo (1997)
Gene rearrangement: a novel mechanism for MDR-1 gene activation.The Journal of clinical investigation, 99 8
V. Bramwell, D. Morris, D. Ernst, I. Hings, M. Blackstein, P. Venner, E. Ette, M. Harding, A. Waxman, G. Demetri (2002)
Safety and efficacy of the multidrug-resistance inhibitor biricodar (VX-710) with concurrent doxorubicin in patients with anthracycline-resistant advanced soft tissue sarcoma.Clinical cancer research : an official journal of the American Association for Cancer Research, 8 2
H. Burger, H. Tol, A. Boersma, Mariël Brok, E. Wiemer, G. Stoter, K. Nooter (2004)
Imatinib mesylate (STI571) is a substrate for the breast cancer resistance protein (BCRP)/ABCG2 drug pump.Blood, 104 9
M. Al-Hajj, M. Becker, M. Wicha, I. Weissman, M. Clarke (2004)
Therapeutic implications of cancer stem cells.Current opinion in genetics & development, 14 1
Sheila Singh, I. Clarke, T. Hide, P. Dirks (2004)
Cancer stem cells in nervous system tumorsOncogene, 23
Sheng Zhou, J. Morris, Y. Barnes, Lu-bin Lan, J. Schuetz, B. Sorrentino (2002)
Bcrp1 gene expression is required for normal numbers of side population stem cells in mice, and confers relative protection to mitoxantrone in hematopoietic cells in vivoProceedings of the National Academy of Sciences of the United States of America, 99
A. Sandler, M. Gordon, D. Alwis, I. Pouliquen, L. Green, P. Marder, A. Chaudhary, K. Fife, L. Battiato, C. Sweeney, Christopher Jordan, Michael Burgess, C. Slapak (2004)
A Phase I Trial of a Potent P-Glycoprotein Inhibitor, Zosuquidar Trihydrochloride (LY335979), Administered Intravenously in Combination with Doxorubicin in Patients with Advanced MalignancyClinical Cancer Research, 10
S. Bates, Susan Bakke, Min Kang, R. Robey, S. Zhai, P. Thambi, Clara Chen, Sheela Patil, Tom Smith, S. Steinberg, M. Merino, B. Goldspiel, B. Meadows, W. Stein, P. Choyke, F. Balis, W. Figg, T. Fojo (2004)
A Phase I/II Study of Infusional Vinblastine with the P-Glycoprotein Antagonist Valspodar (PSC 833) in Renal Cell CarcinomaClinical Cancer Research, 10
C. Scharenberg, M. Harkey, B. Torok-Storb (2002)
The ABCG2 transporter is an efficient Hoechst 33342 efflux pump and is preferentially expressed by immature human hematopoietic progenitors.Blood, 99 2
M. Dean (1997)
Towards a unified model of tumor suppression: lessons learned from the human patched gene.Biochimica et biophysica acta, 1332 2
(2004)
Imatinib mesylate ( STI 571 ) is a substrate for the breast cancer resistance protein ( BCRP ) / ABCG 2 drug pump
M. Bakker, W. Graaf, D. Piers, E. Franssen, H. Groen, E. Smit, W. Kool, H. Hollema, E. Müller, E. Vries (1999)
99mTc-Sestamibi scanning with SDZ PSC 833 as a functional detection method for resistance modulation in patients with solid tumours.Anticancer research, 19 3B
R. Rago, A. Einstein, R. Lush, T. Beer, Y. Ko, W. Henner, G. Bubley, E. Merica, V. Garg, E. Ette, M. Harding, W. Dalton (2003)
Safety and efficacy of the MDR inhibitor Incel (biricodar, VX-710) in combination with mitoxantrone and prednisone in hormone-refractory prostate cancerCancer Chemotherapy and Pharmacology, 51
S. Rabindran, Douglas Ross, L. Doyle, Weidong Yang, L. Greenberger (2000)
Fumitremorgin C reverses multidrug resistance in cells transfected with the breast cancer resistance protein.Cancer research, 60 1
T. Knutsen, L. Mickley, T. Ried, E. Green, S. Manoir, E. Schröck, M. Macville, Y. Ning, R. Robey, M. Polymeropoulos, R. Torres, T. Fojo (1998)
Cytogenetic and molecular characterization of random chromosomal rearrangements activating the drug resistance gene, MDR1/P‐glycoprotein, in drug‐selected cell lines and patients with drug refractory ALLGenes, 23
I. Damjanov (1990)
Teratocarcinoma stem cells.Cancer surveys, 9 2
P. Greenberg, Sandra Lee, R. Advani, M. Tallman, B. Sikic, L. Letendre, K. Dugan, B. Lum, D. Chin, G. Dewald, E. Paietta, J. Bennett, J. Rowe (2004)
Mitoxantrone, etoposide, and cytarabine with or without valspodar in patients with relapsed or refractory acute myeloid leukemia and high-risk myelodysplastic syndrome: a phase III trial (E2995).Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 22 6
S. Thayer, M. Magliano, P. Heiser, Corinne Nielsen, D. Roberts, G. Lauwers, Y. Qi, Stephan Gysin, C. Castillo, V. Yajnik, B. Antoniu, M. McMahon, A. Warshaw, M. Hebrok (2003)
Hedgehog is an early and late mediator of pancreatic cancer tumorigenesisNature, 425
J. Green (2003)
Mouse models of human breast cancer: evolution or convolution?Breast Cancer Research : BCR, 5
W. Dalton, J. Crowley, S. Salmon, T. Grogan, L. Laufman, G. Weiss, J. Bonnet (1995)
A phase III randomized study of oral verapamil as a chemosensitizer to reverse drug resistance in patients with refractory myeloma. A southwest oncology group studyCancer, 75
T. Mizoguchi, Kazutaka Yamada, T. Furukawa, K. Hidaka, Takeharu Hisatsugu, Hisaaki Shimazu, Takashi Tsuruo, T. Sumizawa, Shin-ichi Akiyama (1990)
Expression of the MDR1 gene in human gastric and colorectal carcinomas.Journal of the National Cancer Institute, 82 21
M. Dean, Y. Hamon, G. Chimini (2001)
The human ATP-binding cassette (ABC) transporter superfamily.Journal of lipid research, 42 7
S. Cisternino, C. Mercier, F. Bourasset, F. Roux, J. Scherrmann (2004)
Expression, up-regulation, and transport activity of the multidrug-resistance protein Abcg2 at the mouse blood-brain barrier.Cancer research, 64 9
A. Sparreboom, A. Planting, R. Jewell, M. Burg, A. Gaast, P. Bruijn, W. Loos, K. Nooter, L. Chandler, E. Paul, P. Wissel, J. Verweij (1999)
Clinical pharmacokinetics of doxorubicin in combination with GF120918, a potent inhibitor of MDR1 P-glycoprotein.Anti-cancer drugs, 10 8
M. Baer, S. George, R. Dodge, Kieran O’Loughlin, H. Minderman, M. Caligiuri, J. Anastasi, B. Powell, J. Kolitz, C. Schiffer, C. Bloomfield, R. Larson (2002)
Phase 3 study of the multidrug resistance modulator PSC-833 in previously untreated patients 60 years of age and older with acute myeloid leukemia: Cancer and Leukemia Group B Study 9720.Blood, 100 4
D. Bonnet, J. Dick (1997)
Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cellNature Medicine, 3
Sarah Paterson, Kevin Smith, T. Holyoake, H. Jørgensen (2003)
Is there a cloud in the silver lining for imatinib?British Journal of Cancer, 88
MJ Millward, B. Cantwell, NC Munro, A. Robinson, PA Corris, AL Harris (1993)
Oral verapamil with chemotherapy for advanced non-small cell lung cancer: a randomised study.British Journal of Cancer, 67
J. Jonker, M. Buitelaar, E. Wagenaar, M. Valk, G. Scheffer, R. Scheper, T. Plösch, F. Kuipers, R. Elferink, H. Rosing, J. Beijnen, A. Schinkel (2002)
The breast cancer resistance protein protects against a major chlorophyll-derived dietary phototoxin and protoporphyriaProceedings of the National Academy of Sciences of the United States of America, 99
G. Richardson, C. Robson, S. Lang, D. Neal, N. Maitland, A. Collins (2004)
CD133, a novel marker for human prostatic epithelial stem cellsJournal of Cell Science, 117
D. Berman, S. Karhadkar, A. Hallahan, Joel Pritchard, C. Eberhart, D. Watkins, James Chen, M. Cooper, J. Taipale, J. Olson, P. Beachy (2002)
Medulloblastoma Growth Inhibition by Hedgehog Pathway BlockadeScience, 297
T. Jenkins, C. Tangen, J. Macdonald, G. Weiss, R. Chapman, A. Hantel (1993)
A Southwest Oncology Group study
A. Terunuma, Kimberly Jackson, V. Kapoor, W. Telford, J. Vogel (2003)
Side population keratinocytes resembling bone marrow side population stem cells are distinct from label-retaining keratinocyte stem cells.The Journal of investigative dermatology, 121 5
M. Al-Hajj, M. Wicha, Adalberto Benito-Hernández, S. Morrison, M. Clarke (2003)
Prospective identification of tumorigenic breast cancer cellsProceedings of the National Academy of Sciences of the United States of America, 100
David Berman, S. Karhadkar, A. Maitra, Rocio Oca, M. Gerstenblith, K. Briggs, Antony Parker, Y. Shimada, James Eshleman, D. Watkins, P. Beachy (2003)
Widespread requirement for Hedgehog ligand stimulation in growth of digestive tract tumoursNature, 425
J. Allen, A. Loevezijn, Jeany Lakhai, M. Valk, O. Tellingen, G. Reid, J. Schellens, G. Koomen, A. Schinkel (2002)
Potent and specific inhibition of the breast cancer resistance protein multidrug transporter in vitro and in mouse intestine by a novel analogue of fumitremorgin C.Molecular cancer therapeutics, 1 6
G. Wishart, D. Bissett, J. Paul, D. Jodrell, A. Harnett, T. Habeshaw, D. Kerr, M. Macham, M. Soukop, R. Leonard (1994)
Quinidine as a resistance modulator of epirubicin in advanced breast cancer: mature results of a placebo-controlled randomized trial.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 12 9
M. Kim, H. Turnquist, John Jackson, M. Sgagias, Ying Yan, M. Gong, M. Dean, J. Sharp, K. Cowan (2002)
The multidrug resistance transporter ABCG2 (breast cancer resistance protein 1) effluxes Hoechst 33342 and is overexpressed in hematopoietic stem cells.Clinical cancer research : an official journal of the American Association for Cancer Research, 8 1
D. Belpomme, S. Gauthier, E. Pujade-Lauraine, T. Facchini, M. Goudier, I. Krakowski, G. Netter-Pinon, M. Frénay, C. Gousset, F. Marie, M. Benmiloud, F. Sturtz (2000)
Verapamil increases the survival of patients with anthracycline-resistant metastatic breast carcinoma.Annals of oncology : official journal of the European Society for Medical Oncology, 11 11
P. Houghton, G. Germain, F. Harwood, J. Schuetz, C. Stewart, E. Buchdunger, P. Traxler (2004)
Imatinib Mesylate Is a Potent Inhibitor of the ABCG2 (BCRP) Transporter and Reverses Resistance to Topotecan and SN-38 in VitroCancer Research, 64
B. Mintz, K. Illmensee (1975)
Normal genetically mosaic mice produced from malignant teratocarcinoma cells.Proceedings of the National Academy of Sciences of the United States of America, 72 9
A. Lechner, C. Leech, E. Abraham, A. Nolan, J. Habener (2002)
Nestin-positive progenitor cells derived from adult human pancreatic islets of Langerhans contain side population (SP) cells defined by expression of the ABCG2 (BCRP1) ATP-binding cassette transporter.Biochemical and biophysical research communications, 293 2
S. Sell (2004)
Stem cell origin of cancer and differentiation therapy.Critical reviews in oncology/hematology, 51 1
M. Agrawal, J. Abraham, F. Balis, M. Edgerly, W. Stein, S. Bates, T. Fojo, Clara Chen (2003)
Increased 99mTc-sestamibi accumulation in normal liver and drug-resistant tumors after the administration of the glycoprotein inhibitor, XR9576.Clinical cancer research : an official journal of the American Association for Cancer Research, 9 2
R. Allikmets, L. Schriml, A. Hutchinson, Vincenzo, Romano-Spica, Michael, Dean (1998)
A human placenta-specific ATP-binding cassette gene (ABCP) on chromosome 4q22 that is involved in multidrug resistance.Cancer research, 58 23
M. Gottesman, T. Fojo, S. Bates (2002)
Multidrug resistance in cancer: role of ATP–dependent transportersNature Reviews Cancer, 2
P. Walsh (2005)
Hedgehog signalling in prostate regeneration, neoplasia and metastasis.The Journal of urology, 173 4
J. Dick (2003)
Breast cancer stem cells revealedProceedings of the National Academy of Sciences of the United States of America, 100
T. Lapidot, C. Sirard, J. Vormoor, B. Murdoch, T. Hoang, J. Cáceres-Cortés, M. Minden, B. Paterson, M. Caligiuri, J. Dick (1994)
A cell initiating human acute myeloid leukaemia after transplantation into SCID miceNature, 367
S. Bates, L. Mickley, Y. Chen, N. Richert, J. Rudick, J. Biedler, A. Fojo (1989)
Expression of a drug resistance gene in human neuroblastoma cell lines: modulation by retinoic acid-induced differentiationMolecular and Cellular Biology, 9
D. Watkins, D. Berman, Scott Burkholder, Baolin Wang, P. Beachy, S. Baylin (2003)
Hedgehog signalling within airway epithelial progenitors and in small-cell lung cancerNature, 422
ES Guns, T Denyssevych, R Dixon, MB Bally, L Mayer (2002)
Drug interaction studies between paclitaxel (Taxol) and OC144-093 — a new modulator of MDR in cancer chemotherapyEur. J. Drug Metab. Pharmacokinet., 27
A. Cozzio, E. Passegué, P. Ayton, H. Karsunky, M. Cleary, I. Weissman (2003)
Similar MLL-associated leukemias arising from self-renewing stem cells and short-lived myeloid progenitors.Genes & development, 17 24
T. Reya, S. Morrison, M. Clarke, I. Weissman (2001)
Stem cells, cancer, and cancer stem cellsNature, 414
T. Kondo, T. Setoguchi, T. Taga (2004)
Persistence of a small subpopulation of cancer stem-like cells in the C6 glioma cell line.Proceedings of the National Academy of Sciences of the United States of America, 101 3
M. Goodell, Katja Brose, Glenn Paradis, A. Conner, R. Mulligan (1996)
Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivoThe Journal of Experimental Medicine, 183
K. Miyake, L. Mickley, T. Litman, Z. Zhan, R. Robey, Barbara Cristensen, Mariafiorella Brangi, L. Greenberger, Michael Dean, T. Fojo, S. Bates (1999)
Molecular cloning of cDNAs which are highly overexpressed in mitoxantrone-resistant cells: demonstration of homology to ABC transport genes.Cancer research, 59 1
P. Ruvolo, M. Hawkins (2002)
Bryostatin-I—An Antineoplastic Treasure from the Deep?Cancer Biology & Therapy, 1
M. Dean, A. Rzhetsky, R. Allikmets (2001)
The human ATP-binding cassette (ABC) transporter superfamily.Genome research, 11 7
N. Sato, P. Leopold, R. Crystal (2001)
Effect of adenovirus-mediated expression of Sonic hedgehog gene on hair regrowth in mice with chemotherapy-induced alopecia.Journal of the National Cancer Institute, 93 24
C. Nüsslein-Volhard, E. Wieschaus (1980)
Mutations affecting segment number and polarity in DrosophilaNature, 287
Sheng Zhou, J. Schuetz, K. Bunting, A. Colapietro, J. Sampath, J. Morris, I. Lagutina, G. Grosveld, M. Osawa, H. Nakauchi, B. Sorrentino (2001)
The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotypeNature Medicine, 7
E. Kordon, Gilbert Smith (1998)
An entire functional mammary gland may comprise the progeny from a single cell.Development, 125 10
Shui-Zhong Yan, D. Hahn, Zhihua Huang, Wei-Jen Tang (1996)
Two Cytoplasmic Domains of Mammalian Adenylyl Cyclase Form a G- and Forskolin-activated Enzyme in Vitro(*)The Journal of Biological Chemistry, 271
C. Southam, A. Brunschwig (1961)
Quantitative studies of autotransplantation of human cancer. Preliminary reportCancer, 14
S. Graham, H. Jørgensen, E. Allan, C. Pearson, M. Alcorn, L. Richmond, T. Holyoake (2002)
Primitive, quiescent, Philadelphia-positive stem cells from patients with chronic myeloid leukemia are insensitive to STI571 in vitro.Blood, 99 1
M. Seiden, K. Swenerton, U. Matulonis, S. Campos, P. Rose, G. Batist, E. Ette, V. Garg, A. Fuller, M. Harding, D. Charpentier (2002)
A phase II study of the MDR inhibitor biricodar (INCEL, VX-710) and paclitaxel in women with advanced ovarian cancer refractory to paclitaxel therapy.Gynecologic oncology, 86 3
J. Price, D. Tarin (1989)
Low incidence of tumourigenicity in agarose colonies from spontaneous murine mammary tumours.Differentiation; research in biological diversity, 41 3
C. Roche-Lestienne, V. Soenen-Cornu, Nathalie Grardel-Duflos, J. Laï, N. Philippe, T. Facon, P. Fenaux, C. Preudhomme (2002)
Several types of mutations of the Abl gene can be found in chronic myeloid leukemia patients resistant to STI571, and they can pre-exist to the onset of treatment.Blood, 100 3
Xiao Wu, Elena Rabkin-Aikawa, K. Guleserian, Tjorvi Perry, Yutaka Masuda, Fraser Sutherland, F. Schoen, J. Mayer, J. Bischoff (2004)
Tissue-engineered microvessels on three-dimensional biodegradable scaffolds using human endothelial progenitor cells.American journal of physiology. Heart and circulatory physiology, 287 2
P. Sonneveld, S. Suciu, P. Weijermans, M. Beksaç, R. Neuwirtová, G. Solbu, Lokhorst Hm, J. Lelie, H. Dōhner, H. Gerhartz, C. Segeren, R. Willemze, B. Lowenberg (2001)
Cyclosporin A combined with vincristine, doxorubicin and dexamethasone (VAD) compared with VAD alone in patients with advanced refractory multiple myeloma: an EORTC–HOVON randomized phase III study (06914)British Journal of Haematology, 115
R. Peck, J. Hewett, M. Harding, Y. Wang, P. Chaturvedi, A. Bhatnagar, H. Ziessman, F. Atkins, M. Hawkins (2001)
Phase I and pharmacokinetic study of the novel MDR1 and MRP1 inhibitor biricodar administered alone and in combination with doxorubicin.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 19 12
C. Ozvegy-Laczka, T. Hegedűs, G. Várady, O. Ujhelly, J. Schuetz, A. Váradi, G. Kéri, L. Őrfi, K. Német, B. Sarkadi (2004)
High-affinity interaction of tyrosine kinase inhibitors with the ABCG2 multidrug transporter.Molecular pharmacology, 65 6
Alan List, K. Kopecky, C. Willman, David Head, Diane Persons, M. Slovak, Robert Dorr, C. Karanes, Harry Hynes, J. Doroshow, Muhammad Shurafa, Frederick Appelbaum (2001)
Benefit of cyclosporine modulation of drug resistance in patients with poor-risk acute myeloid leukemia: a Southwest Oncology Group study.Blood, 98 12
D. Toppmeyer, A. Seidman, M. Pollak, C. Russell, K. Tkaczuk, S. Verma, B. Overmoyer, V. Garg, E. Ette, M. Harding, G. Demetri (2002)
Safety and efficacy of the multidrug resistance inhibitor Incel (biricodar; VX-710) in combination with paclitaxel for advanced breast cancer refractory to paclitaxel.Clinical cancer research : an official journal of the American Association for Cancer Research, 8 3
J. Goldie, A. Coldman (1979)
A mathematic model for relating the drug sensitivity of tumors to their spontaneous mutation rate.Cancer treatment reports, 63 11-12
R. Milroy, and Rese (1993)
A randomised clinical study of verapamil in addition to combination chemotherapy in small cell lung cancer. West of Scotland Lung Cancer Research Group, and the Aberdeen Oncology Group.British Journal of Cancer, 68
B. Lassalle, Henri Bastos, J. Louis, L. Riou, J. Testart, B. Dutrillaux, P. Fouchet, I. Allemand (2003)
`Side Population' cells in adult mouse testis express Bcrp1 gene and are enriched in spermatogonia and germinal stem cells, 131
M. Bakker, W. Graaf, D. Piers, E. Franssen, H. Groen, E. Smit, W. Kool, H. Hollema, E. Muller, E. Vries (1999)
Tc-99m-Sestamibi scanning with SDZ PSC 833 as a functional detection method for resistance modulation in patients with solid tumoursAnticancer Research, 19
Sheng Zhou, Y. Zong, T. Lu, B. Sorrentino (2003)
Hematopoietic cells from mice that are deficient in both Bcrp1/Abcg2 and Mdr1a/1b develop normally but are sensitized to mitoxantrone.BioTechniques, 35 6
H. Hahn, J. Christiansen, C. Wicking, P. Zaphiropoulos, A. Chidambaram, B. Gerrard, I. Vořechovský, A. Bale, R. Toftgård, M. Dean, B. Wainwright (1996)
A Mammalian patched Homolog Is Expressed in Target Tissues of sonic hedgehog and Maps to a Region Associated with Developmental Abnormalities (*)The Journal of Biological Chemistry, 271
A. Alvi, Helen Clayton, Chirag Joshi, T. Enver, A. Ashworth, M. Vivanco, T. Dale, M. Smalley (2002)
Functional and molecular characterisation of mammary side population cellsBreast Cancer Research, 5
L. Zuylen, A. Sparreboom, A. Gaast, M. Burg, V. Beurden, C. Bol, R. Woestenborghs, P. Palmer, J. Verweij (2000)
The orally administered P-glycoprotein inhibitor R101933 does not alter the plasma pharmacokinetics of docetaxel.Clinical cancer research : an official journal of the American Association for Cancer Research, 6 4
L. Doyle, Weidong Yang, L. Abruzzo, Tammy Krogmann, Y. Gao, A. Rishi, Douglas Ross (1998)
A multidrug resistance transporter from human MCF-7 breast cancer cells.Proceedings of the National Academy of Sciences of the United States of America, 95 26
Sheila Singh, I. Clarke, Mizuhiko Terasaki, Victoria Bonn, C. Hawkins, J. Squire, P. Dirks (2003)
Identification of a cancer stem cell in human brain tumors.Cancer research, 63 18
Melissa Holtz, M. Slovak, Feiyu Zhang, C. Sawyers, S. Forman, R. Bhatia (2002)
Imatinib mesylate (STI571) inhibits growth of primitive malignant progenitors in chronic myelogenous leukemia through reversal of abnormally increased proliferation.Blood, 99 10
A. Asakura, M. Rudnicki (2002)
Side population cells from diverse adult tissues are capable of in vitro hematopoietic differentiation.Experimental hematology, 30 11
P. Alexander (1968)
Cancer ChemotherapyNature, 217
Stem-cell populations have been identified in a range of haematopoietic and solid tumours, and might represent the cell of origin of these tumours. Normal and cancer stem cells express high levels of ATP-binding cassette (ABC) transporters, such as ABCB1, which encodes P-glycoprotein, and the half-transporter ABCG2, which was originally identified in mitoxantrone-resistant cells. The drug-transporting property of stem cells conferred by ABC transporters is the basis for the 'side-population' phenotype that arises from the exclusion of the fluorescent dye Hoechst 33342. Cancer stem cells are likely to share many of the properties of normal stem cells that provide for a long lifespan, including relative quiescence, resistance to drugs and toxins through the expression of several ABC transporters, an active DNA-repair capacity and a resistance to apoptosis. Therefore, tumours might have a built-in population of drug-resistant pluripotent cells that can survive chemotherapy and repopulate the tumour.
Nature Reviews Cancer – Springer Journals
Published: Apr 1, 2005
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.